The store will not work correctly when cookies are disabled.
4-(3-Ethyl-2,4,4-trimethylcyclohex-2-enylidenemethyl)benzamide
ID: ALA3262378
PubChem CID: 90676375
Max Phase: Preclinical
Molecular Formula: C19H25NO
Molecular Weight: 283.42
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CCC1=C(C)/C(=C/c2ccc(C(N)=O)cc2)CCC1(C)C
Standard InChI: InChI=1S/C19H25NO/c1-5-17-13(2)16(10-11-19(17,3)4)12-14-6-8-15(9-7-14)18(20)21/h6-9,12H,5,10-11H2,1-4H3,(H2,20,21)/b16-12+
Standard InChI Key: WAIVFZDQYZVFJB-FOWTUZBSSA-N
Molfile:
RDKit 2D
21 22 0 0 0 0 0 0 0 0999 V2000
25.9946 -3.0063 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.5860 -3.7154 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7688 -3.7154 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3602 -4.4245 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5430 -4.4245 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1344 -3.7154 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5430 -3.0063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3602 -3.0063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.9946 -4.4245 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.3131 -3.7154 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9045 -3.0063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0873 -3.0063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6787 -2.3013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0873 -1.5922 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9045 -1.5922 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3131 -2.3013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2322 -0.7897 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3201 -1.3132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6787 -3.7154 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8616 -2.3013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4530 -1.5922 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
3 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
3 8 2 0
2 9 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 1 0
15 16 1 0
11 16 1 0
14 17 1 0
14 18 1 0
12 19 1 0
20 21 1 0
13 20 1 0
10 11 2 0
6 10 1 0
1 2 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 283.42 | Molecular Weight (Monoisotopic): 283.1936 | AlogP: 4.72 | #Rotatable Bonds: 3 |
Polar Surface Area: 43.09 | Molecular Species: NEUTRAL | HBA: 1 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 2 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 4.22 | CX LogD: 4.22 |
Aromatic Rings: 1 | Heavy Atoms: 21 | QED Weighted: 0.86 | Np Likeness Score: 0.28 |
References
1. Zatelli MC, Gagliano T, Pelà M, Bianco S, Bertolasi V, Tagliati F, Guerrini R, degli Uberti E, Salvadori S, Trapella C.. (2014) N-carbamidoyl-4-((3-ethyl-2,4,4-trimethylcyclohexyl)methyl)benzamide enhances staurosporine cytotoxic effects likely inhibiting the protective action of Magmas toward cell apoptosis., 57 (11): [PMID:24761782] [10.1021/jm5000535] |